S. Boppudi Et Al. , "Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis," CLINICAL GENETICS , vol.90, no.4, pp.334-342, 2016
Boppudi, S. Et Al. 2016. Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis. CLINICAL GENETICS , vol.90, no.4 , 334-342.
Boppudi, S., Boegershausen, N., Hove, H. B., Percin, E. F., Aslan, D., Dvorsky, R., ... Kayhan, G.(2016). Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis. CLINICAL GENETICS , vol.90, no.4, 334-342.
Boppudi, S. Et Al. "Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis," CLINICAL GENETICS , vol.90, no.4, 334-342, 2016
Boppudi, S. Et Al. "Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis." CLINICAL GENETICS , vol.90, no.4, pp.334-342, 2016
Boppudi, S. Et Al. (2016) . "Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis." CLINICAL GENETICS , vol.90, no.4, pp.334-342.
@article{article, author={S. Boppudi Et Al. }, title={Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis}, journal={CLINICAL GENETICS}, year=2016, pages={334-342} }